Insmed Incorporated IM8N.F Stock
Insmed Incorporated Price Chart
Insmed Incorporated IM8N.F Financial and Trading Overview
| Insmed Incorporated stock price | 26.6 EUR |
| Previous Close | 17.7 EUR |
| Open | 18.2 EUR |
| Bid | 18.2 EUR x 20000 |
| Ask | 18.4 EUR x 20000 |
| Day's Range | 18.2 - 18.2 EUR |
| 52 Week Range | 14.8 - 27.4 EUR |
| Volume | 200 EUR |
| Avg. Volume | 6 EUR |
| Market Cap | 2.48B EUR |
| Beta (5Y Monthly) | 1.526408 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.98 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.78 EUR |
IM8N.F Valuation Measures
| Enterprise Value | 2.83B EUR |
| Trailing P/E | N/A |
| Forward P/E | -5.652174 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.644342 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 11.003 |
| Enterprise Value/EBITDA | -5.376 |
Trading Information
Insmed Incorporated Stock Price History
| Beta (5Y Monthly) | 1.526408 |
| 52-Week Change | 9.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.4 EUR |
| 52 Week Low | 14.8 EUR |
| 50-Day Moving Average | 16.9 EUR |
| 200-Day Moving Average | 18.86 EUR |
IM8N.F Share Statistics
| Avg. Volume (3 month) | 6 EUR |
| Avg. Daily Volume (10-Days) | 20 EUR |
| Shares Outstanding | 136.43M |
| Float | 134.67M |
| Short Ratio | N/A |
| % Held by Insiders | 1.12% |
| % Held by Institutions | 107.83% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -212.33% |
| Operating Margin (ttm) | -207.53% |
| Gross Margin | 77.95% |
| EBITDA Margin | -204.68% |
Management Effectiveness
| Return on Assets (ttm) | -25.0060% |
| Return on Equity (ttm) | -1453.40% |
Income Statement
| Revenue (ttm) | 257.46M EUR |
| Revenue Per Share (ttm) | 2.02 EUR |
| Quarterly Revenue Growth (yoy) | 22.80% |
| Gross Profit (ttm) | 190.23M EUR |
| EBITDA | -526979008 EUR |
| Net Income Avi to Common (ttm) | -546676992 EUR |
| Diluted EPS (ttm) | -3.84 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 998.68M EUR |
| Total Cash Per Share (mrq) | 7.32 EUR |
| Total Debt (mrq) | 1.33B EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.006 |
| Book Value Per Share (mrq) | -0.327 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -441580992 EUR |
| Levered Free Cash Flow (ttm) | -238658000 EUR |
Profile of Insmed Incorporated
| Country | Germany |
| State | NJ |
| City | Bridgewater |
| Address | 700 US Highway 202/206 |
| ZIP | 08807 |
| Phone | 908 977 9900 |
| Website | https://www.insmed.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 736 |
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Q&A For Insmed Incorporated Stock
What is a current IM8N.F stock price?
Insmed Incorporated IM8N.F stock price today per share is 26.6 EUR.
How to purchase Insmed Incorporated stock?
You can buy IM8N.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Insmed Incorporated?
The stock symbol or ticker of Insmed Incorporated is IM8N.F.
Which industry does the Insmed Incorporated company belong to?
The Insmed Incorporated industry is Biotechnology.
How many shares does Insmed Incorporated have in circulation?
The max supply of Insmed Incorporated shares is 148.56M.
What is Insmed Incorporated Price to Earnings Ratio (PE Ratio)?
Insmed Incorporated PE Ratio is now.
What was Insmed Incorporated earnings per share over the trailing 12 months (TTM)?
Insmed Incorporated EPS is -4.98 EUR over the trailing 12 months.
Which sector does the Insmed Incorporated company belong to?
The Insmed Incorporated sector is Healthcare.